Skip to main content
Premium Trial:

Request an Annual Quote

New Products: CGC Genetics' Diabetes/Obesity Mutation Panel

Premium

Portuguese genetic testing firm CGC Genetics recently launched a Diabetes/Obesity Mutation Panel that it claims can be used for preventive purposes.

The new test is done by microarray hybridization and screens a total of 76 markers: 38 polymorphisms on genes or loci associated with diabetes and 38 associated with obesity.

According to CGC, the test can be used to identify which individuals may benefit from an early therapeutic intervention to prevent disease progression.

The Scan

Unwrapping Mummies' Faces

LiveScience reports that Parabon NanoLabs researchers have reconstructed how three Egyptian mummies may have looked.

Study on Hold

The Spectrum 10K study has been put on hold due to a backlash, leading the researchers to conduct consultations with the autism community, Nature News reports.

Others Out There Already

Reuters reports that Sanofi is no longer developing an mRNA-based vaccine for SARS-CoV-2.

PNAS Papers on GWAS False Discovery, PRAMEF2 Role in Tumorigenesis, RNA Virus Reverse Genetics

In PNAS this week: strategy to account for GWAS false-discovery rates, role of PRAMEF2 in cancer development, and more.